REGN (REGENERON PHARMACEUTICALS) Institutional Ownership Summary
Based on the latest SEC 13F filings, 5 institutional investors hold REGN (REGENERON PHARMACEUTICALS) with a combined value of $7.54B across 9,773,194 shares. The largest holder is BlackRock, Inc. with a position worth $6.75B (0.11% of their portfolio). 2 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$7.54B
Total Shares Held
9,773,194
Institutional Holders
5
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $6.75B | 0.11% | -1.1% |
| 2 | CITADEL ADVISORS LLC | $528.17M | 0.08% | +13.3% |
| 3 | Point72 Asset Management, L.P. | $205.18M | 0.23% | +31.9% |
| 4 | Bridgewater Associates, LP | $56.15M | 0.20% | -69.1% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $7.01M | 0.01% | -96.7% |